The India home diagnostic testing market was valued at USD 411.83 Million in 2025 and is expected to grow at a CAGR of 4.80%, reaching USD 658.16 Million by 2035. The market growth is driven by increasing access to convenient at-home testing solutions supported by strategic collaborations, rising investments and growing awareness around early detection and preventive healthcare across the region.
Base Year
Historical Period
Forecast Period
Growing demand for early detection and home-friendly health solutions is expected to push the market forward, increasing the adoption of reliable remote health monitoring tools among diverse age groups.
Rising investments, strategic partnerships and technology upgrades are strengthening service accessibility, encouraging faster rollout of user-centric testing options that enhance everyday healthcare convenience across India.
New product launches and AI-driven diagnostic innovations are reshaping consumer behaviour, promoting wider acceptance of simple, accurate and home-based testing formats suitable for routine wellness checks.
Compound Annual Growth Rate
4.8%
Value in USD Million
2026-2035
*this image is indicative*
The market is steadily expanding as people increasingly prefer quick, private and convenient ways to monitor their health. Rising awareness about early detection, growth in chronic conditions and wider access to digital health platforms are further boosting demand. Recent collaborations, funding inflows and the launch of innovative at-home services are strengthening the market landscape. With companies focusing on user-friendly test kits and portable devices, the country is moving toward more accessible and proactive care. This shift continues to elevate the relevance of reliable home diagnostic kits across India.
Strategic Collaborations Propelling the Market Expansion
Growing momentum in decentralized healthcare is emerging as a strong growth driver for the market, enabling individuals to access convenient and reliable testing from the comfort of their homes. For instance, in February 2025, Metropolis Healthcare Limited partnered with Roche Diagnostics India to launch a self-sampling HPV DNA test, empowering women to collect samples privately and confidently. This WHO-approved method removes barriers linked to stigma and travel, expanding preventive care access nationwide. Such advancements continue to accelerate the demand for high-quality at-home medical testing solutions in India’s diagnostic ecosystem.
Rising Fundings to Accelerate the India Home Diagnostic Testing Market Value
Growing investor interest is expected to be a strong growth driver in the market, as increased capital allows healthcare innovators to expand faster and bring convenient testing solutions closer to consumers. For instance, in June 2025, Biopeak secured USD 3.5 million in seed funding to scale its AI-driven preventive health clinics across India, demonstrating strong confidence in next-generation diagnostic services. This rising financial support is also encouraging more startups to explore accessible and affordable testing models that fit into everyday routines. Such momentum strengthens the demand for reliable home diagnostic kits, supporting the country’s shift toward proactive and technology-enabled healthcare.
The market is witnessing several emerging trends, including a surge in new diagnostic service launches, expanding healthcare innovation platforms and growing consumer preference for fast, tech-enabled home testing solutions.
New Diagnostic Launches to Boost the India Home Diagnostic Testing Market
Growing momentum around new service launches is becoming a defining trend in the market, as consumers increasingly prefer convenient and technology-driven health solutions. For example, in June 2025, Amazon India introduced its at-home diagnostic service, offering quick sample collection and fast digital reports through the Amazon app. This move reflects a strong shift toward simplified healthcare access where trusted brands bring testing directly to people’s homes. Such innovation is boosting interest in efficient home health testing options across the country.
Growing Healthcare Innovation Fuelling the India Home Diagnostic Testing Market Growth
The launch of an all-in-one support platform is boosting the diagnostics industry across India. For instance, in September 2025, Andhra Pradesh MedTech Zone introduced the iPassport, a gateway offering startups access to advanced R&D, testing labs, manufacturing facilities, regulatory guidance and mentorship. This initiative is helping innovators move smoothly from prototype to product. As a result, the supportive ecosystem is driving demand for advanced home diagnostic technology while encouraging the creation of new devices designed for home use across the country.
Blood Expected to Lead the Market Share by Sample
Blood is anticipated to lead the segment because it offers the highest accuracy and is widely used for diagnosing chronic conditions, infections and nutrient deficiencies. Growing awareness around preventive healthcare is also encouraging people to choose blood tests for clearer insights into their overall wellness. With rising demand for early detection and home-friendly test kits, consumers increasingly rely on blood samples for quick and trustworthy results. This shift is also pushing companies to develop more portable devices and user-focused solutions, strengthening India’s adoption of modern home diagnostic technology. The remaining segments include urine, saliva and others.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1897 and headquartered in New Jersey, Becton, Dickinson and Company has grown into one of the most influential players in the global diagnostics ecosystem. The company has consistently focused on advancing sample collection systems, rapid testing tools and safety-engineered devices. Its contributions strengthen the home diagnostic landscape by improving accuracy, ease of use and access to essential testing. BD’s continued investment in innovation supports the rising demand for reliable and patient-friendly diagnostic solutions worldwide.
Established in 1888 and headquartered in Illinois, Abbott is one of the world’s leading healthcare companies with a strong focus on diagnostics. Its innovations in glucose monitoring, rapid test kits and connected health devices have transformed how consumers manage everyday health needs. By bringing fast and user-friendly testing solutions into homes, Abbott has played a key role in expanding the home diagnostics market. Its continuous push toward digital and portable technologies support greater accessibility and early detection.
Founded in 1979 and based in California, Quidel Corporation has made its mark through rapid diagnostic testing solutions for infectious diseases and point-of-care screening. The company developed widely used rapid antigen and molecular testing platforms that support faster clinical decisions. Quidel’s focus on affordability, speed and simplicity has encouraged broader adoption of home-based tests. Its ongoing advancements empower users to detect illnesses earlier, contributing to the growing shift toward consumer-friendly diagnostic solutions.
Established in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche is one of the most trusted names in diagnostics and pharmaceuticals. The company has strengthened the diagnostics sector through high-precision instruments, molecular testing technologies and integrated digital solutions. Roche has consistently advanced early detection and at-home testing capabilities, improving patient outcomes and supporting decentralized healthcare models. Its commitment to innovation and accuracy continues to influence global acceptance of home and point-of-care diagnostics.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players include Nova Biomedical, Acon Laboratories, Inc., BTNX, Inc., Medtronic plc, and Siemens Healthcare GmbH.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
Market Breakup by Product
Market Breakup by Sample
Market Breakup by Age Group
Market Breakup by Distribution Channel
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Product |
|
| Breakup by Sample |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share